🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
18,156
Companies
1,062
Drugs tracked
3,187

Quick answer

NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

6,911 results for “Pharma” Clear

  1. Candesartan and standard chronic heart disease therapy

    Takeda Pharmaceuticals International AG

    Heart Failure

    phase 3 small molecule terminated

    1 trial

  2. Cannabidiol (CBD)

    Jazz Pharmaceuticals Ireland Limited

    Clinical High Risk for Psychosis (CHR)

    phase 3 small molecule active

    1 trial

  3. Cannabidiol, pharmaceutically produced with < 5 ppm THC

    Cardiol Therapeutics

    COVID-19

    phase 3 small molecule terminated

    1 trial

  4. Cantharidin

    Verrica Pharmaceuticals

    Common Warts (Verruca Vulgaris)

    phase 3 other active

    1 trial

  5. Capecitabine

    China SXT Pharmaceuticals

    Nasopharyngeal Carcinoma

    phase 3 small molecule active

    1 trial

  6. Capecitabine Accord 150 mg film-coated tablets, Fluorouracil 25 mg/ml Solution for Injection or Infusion, Irinotecan Accord 20 mg/ml Solution à diluer pour perfusion, OXALIPLATINE ARROW LAB 5 mg/mL, solution à diluer pour perfusion, Leucovorin-Teva 10 mg/ml Concentrate for Solution for Infusion

    Cancer Prevention Pharma (Ireland) Limited

    Stage III colorectal cancer

    phase 3 small molecule active

    1 trial

  7. Capox chemotherapy

    China SXT Pharmaceuticals

    Rectal Cancer

    phase 3 small molecule active

    1 trial

  8. Capsule to match PF-06651600 (Ritlecitinib) 50 mg, Ritlecitinib tosilate, DEXAMETHASONE, Capsule to match pf-06651600 (ritlecitinib) 100 mg, Ritlecitinib Tosilate

    Pfizer Ireland Pharmaceuticals Unlimited Company

    NON SEGMENTAL VITILIGO

    phase 3 small molecule active

    1 trial

  9. Carbetocin

    Acadia Pharmaceuticals B.V.

    Hyperphagia in Prader-Willi Syndrome

    phase 3 small molecule active

    2 trials

  10. Carbetocin Nasal Spray

    Pharma Mar S.A.

    Hyperphagia related behaviour associated with Prader-Willi Syndrome (PWS)

    phase 3 small molecule active

    1 trial

  11. Carbetocin Nasal Spray, Placebo to match carbetocin 11.4 mg/ml (2ml /vial)

    Pharma Mar S.A.

    Hyperphagia related behaviour associated with Prader-Willi Syndrome (PWS)

    phase 3 small molecule active

    1 trial

  12. Carboplatin

    Teva Pharma GmbH

    Tubular Breast Cancer Stage II

    phase 3 small molecule completed

    1 trial

  13. Cardioblate® Surgical Ablation System

    China SXT Pharmaceuticals

    Rheumatic Valve Disease

    phase 3 other active

    1 trial

  14. Casgevy 4 - 13 x 10^6 cells/mL dispersion for infusion

    Vertex Pharmaceuticals (Ireland) Limited

    Sickle Cell Disease, Transfusion dependent thalassemia

    phase 3 small molecule active

    1 trial

  15. Casgevy 4 - 13 x 10^6 cells/mL dispersion for infusion, BUSULFAN, FILGRASTIM, PLERIXAFOR

    Vertex Pharmaceuticals (Ireland) Limited

    Transfusion-dependent β-thalassemia (TDT)

    phase 3 small molecule active

    1 trial

  16. Casgevy 4 - 13 x 10^6 cells/mL dispersion for infusion, BUSULFAN, FILGRASTIM, PLERIXAFOR

    Vertex Pharmaceuticals (Ireland) Limited

    Transfusion-Dependent-Thalassemia

    phase 3 small molecule active

    1 trial

  17. Casgevy 4 - 13 x 10^6 cells/mL dispersion for infusion, PLERIXAFOR, BUSULFAN

    Vertex Pharmaceuticals (Ireland) Limited

    Severe sickle cell disease (SCD)

    phase 3 small molecule active

    1 trial

  18. Casodex 50 mg Film-coated Tablets, Zoladex 10,8 mg implantat

    Pharma Mar S.A.

    Metastatic hormone-sensitive prostate cancer with high tumor load

    phase 3 small molecule active

    1 trial

  19. Casodex® 50 mg Film-coated Tablets, ANANDRON 150 mg, comprimé, Flutamide 250 mg Tablets, Xtandi - 40 mg soft capsules

    Cancer Prevention Pharma (Ireland) Limited

    Localised prostate cancer at high risk of recurrence

    phase 3 small molecule active

    1 trial

  20. Cemdisiran, Pozelimab

    Pharma Mar S.A.

    Paroxysmal nocturnal hemoglobinuria (PNH)

    phase 3 small molecule active

    1 trial

  21. Cenestin 0.3 mg Tablets

    Teva Pharma GmbH

    Hot Flashes

    phase 3 small molecule completed

    1 trial

  22. Cerezyme 400 Units Powder for concentrate for solution for infusion, Placebo 15mg tablets, venglustat GZ402671 - SAR402671, Placebo 6mg tablets, Cerezyme 400 Units Powder for concentrate for solution for infusion, Placebo for Cerezyme, Cerezyme 400 Units Powder for concentrate for solution for infusion, venglustat GZ402671 - SAR402671

    Sanofi Pharma Bristol-Myers Squibb

    Gaucher's disease type III

    phase 3 small molecule active

    1 trial

  23. Chickenpox Vaccines

    China SXT Pharmaceuticals

    Chickenpox Vaccines

    phase 3 mab completed

    1 trial

  24. Cholic Acid

    Mirum Pharmaceuticals International B.V.

    Bile Acid Synthesis Defect

    phase 3 small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources